Request for Nominations of Candidates To Serve on the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC)-Health Disparities Subcommittee (HDS), 60355-60356 [2016-21039]
Download as PDF
Federal Register / Vol. 81, No. 170 / Thursday, September 1, 2016 / Notices
1. The Stephen L. LaFrance, Jr. GW
Investments Trust, the Jason P.
LaFrance GW Investments Trust, the
Amy Beth LaFrance GW Investments
Trust, all of Little Rock, Arkansas,
Stephen L. LaFrance, Jr., Little Rock,
Arkansas, as trustee of the Stephen L.
LaFrance, Jr. GW Investments Trust and
co-trustee of the Jason P. LaFrance GW
Investments Trust, and Jason P.
LaFrance, Little Rock, Arkansas, as cotrustee of the Jason P. LaFrance GW
Investments Trust and as trustee of the
Amy Beth LaFrance GW Investments
Trust and the Amy LaFrance Bancroft
GW Investments Revocable Trust, Little
Rock, Arkansas; to acquire voting shares
of Greenwoods Financial Group, Inc.,
Lake Mills, Wisconsin, and thereby join
the existing LaFrance Family Control
Group that was approved to acquire 10
percent or more of the outstanding
shares of Greenwoods Financial Group,
Inc. Greenwoods Financial Group, Inc.
controls The Greenwood’s State Bank,
Lake Mills, Wisconsin.
Board of Governors of the Federal Reserve
System, August 26, 2016.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2016–21009 Filed 8–31–16; 8:45 am]
FEDERAL RESERVE SYSTEM
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
17:14 Aug 31, 2016
Jkt 238001
Board of Governors of the Federal Reserve
System, August 26, 2016.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2016–21010 Filed 8–31–16; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 6210–01–P
VerDate Sep<11>2014
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than September 26,
2016.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Canadian Imperial Bank of
Commerce, Toronto, Canada and its
wholly-owned subsidiary, CIBC Holdco
Inc., New York, New York; to acquire
PrivateBancorp, Inc. and thereby
indirectly acquire The PrivateBank and
Trust Company, both in Chicago,
Illinois.
Request for Nominations of
Candidates To Serve on the Advisory
Committee to the Director, Centers for
Disease Control and Prevention (ACD,
CDC)—Health Disparities
Subcommittee (HDS)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the ACD, CDC–HDS. This
subcommittee consists of up to 16
experts in fields related to health policy,
public health, global health,
preparedness, preventive medicine, the
faith-based and community-based
sector, and allied fields who are selected
by the CDC. The HDS provides
interdisciplinary perspectives and
subject matter expertise to the goal of
reducing health disparities which may
include research, program and policy
analyses, and other developmental
activities for the ACD, CDC on CDC’s
efforts to address health disparities
which is integral to achieving the
agency’s overarching health impact
goals. Specifically, the HDS will submit
work products to the ACD, CDC for
deliberation, discussion, and decision.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the
subcommittee’s mission. Nominees will
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
60355
be selected by the Designated Federal
Officer of the ACD, CDC. Members may
be invited to serve for terms of up to
three years.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership shall be
balanced in terms of professional
training and background, points of view
represented, and the committee’s
function. Appointments shall be made
without discrimination on the basis of
age, race, ethnicity, gender, sexual
orientation, gender identity, HIV status,
disability, and cultural, religious, or
socioeconomic status. Nominees must
be U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
individual service on advisory
committees and multiple committee
memberships. Subcommittee members
are Special Government Employees,
requiring the filing of financial
disclosure reports at the beginning and
annually during their terms.
Note that the need for different
expertise varies from year to year and a
candidate who is not selected in one
year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and
cannot be full-time employees of the
U.S. Government. Candidates should
submit the following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nomination materials must be date
stamped by midnight on September 30,
2016 and sent to: ACDirector@cdc.gov or
to Tracie Strength, Office of the Chief of
Staff, Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
Mailstop D14, Atlanta, Georgia 30329.
Please direct questions to Tracie
Strength at (404)498–6482.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
E:\FR\FM\01SEN1.SGM
01SEN1
60356
Federal Register / Vol. 81, No. 170 / Thursday, September 1, 2016 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–21039 Filed 8–31–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Tribal Consultation Meetings
Office of Head Start (OHS),
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Notice of meeting.
AGENCY:
Pursuant to the Improving
Head Start for School Readiness Act of
2007, Public Law 110–134, notice is
hereby given of a 1-day Tribal
Consultation Session to be held between
the Department of Health and Human
Services (HHS), Administration for
Children and Families, OHS leadership
and the leadership of Tribal
Governments operating Head Start
(including Early Head Start) programs.
The purpose of these Consultation
Sessions is to discuss ways to better
meet the needs of American Indian and
Alaska Native children and their
families, taking into consideration
funding allocations, distribution
formulas, and other issues affecting the
delivery of Head Start services in their
geographic locations [42 U.S.C. 9835,
Section 640(l)(4)].
DATES: October 19, 2016, from 8:00 a.m.
to 1:00 p.m.
LOCATION: ThrivAlaska Head Start
Center at 1949 Gilliam Way, Fairbanks,
Alaska 99701.
FOR FURTHER INFORMATION CONTACT:
Angie Godfrey, Regional Program
Manager, Region XI AI/AN, OHS, email
Angie.Godfrey@acf.hhs.gov, or phone
(202) 205–5811. Additional information
and online meeting registration is
available at: https://
eclkc.ohs.acf.hhs.gov/hslc/hs/calendar/
tc2016.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
HHS
announces OHS Tribal Consultations for
leaders of Tribal Governments operating
Head Start and Early Head Start
programs. The agenda for the scheduled
OHS Tribal Consultations in Fairbanks,
Alaska, will be organized around the
statutory purposes of Head Start Tribal
Consultations related to meeting the
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:14 Aug 31, 2016
Jkt 238001
needs of American Indian and Alaska
Native children and families, taking into
consideration funding allocations,
distribution formulas, and other issues
affecting the delivery of Head Start
services in that geographic location. In
addition, OHS will share actions taken
and in progress to address the issues
and concerns raised in the 2016 OHS
Tribal Consultation.
The Consultation Session will be
conducted with elected or appointed
leaders of Tribal Governments and their
designated representatives [42 U.S.C.
9835, Section 640(l)(4)(A)]. Designees
must have a letter from the Tribal
Government authorizing them to
represent the tribe. Tribal Governments
must submit the designee letter at least
3 days in advance of the Consultation
Session to Angie Godfrey at
Angie.Godfrey@acf.hhs.gov. Other
representatives of tribal organizations
and Native nonprofit organizations are
welcome to attend as observers.
A detailed report of the Consultation
Session will be prepared and made
available within 45 days of the
Consultation Session to all Tribal
Governments receiving funds for Head
Start and Early Head Start programs.
Tribes wishing to submit written
testimony for the report should send
testimony to Angie Godfrey at
Angie.Godfrey@acf.hhs.gov either prior
to the Consultation Session or within 30
days after the meeting. OHS will
summarize oral testimony and
comments from the Consultation
Session in a report without attribution,
along with topics of concern and
recommendations.
Dated: August 26, 2016.
Blanca E. Enriquez,
Director, Office of Head Start.
announcement of the award of 13
single-source grants for a total of
$35,513,938 under the W–F Alternative
Program. The document contained an
incorrect address and telephone
number.
FOR FURTHER INFORMATION CONTACT:
Colleen Mahar-Piersma, Program
Analyst, Office of Refugee Resettlement,
Mary E. Switzer Building, 330 C Street
SW., Washington, DC 20201. Telephone:
202–205–5266; Email: colleen.maharpiersma@acf.hhs.gov.
Correction
In the Federal Register of August 22,
2016, in FR Doc. 2016–19923, on page
56655, in the third column, correct the
FOR FURTHER INFORMATION CONTACT
caption to read: Colleen Mahar-Piersma,
Program Analyst, Office of Refugee
Resettlement, Mary E. Switzer Building,
330 C Street SW., Washington, DC
20201. Telephone: 202–205–5266;
Email: colleen.mahar-piersma@
acf.hhs.gov.
Mary M. Wayland,
Senior Grants Policy Specialist, Division of
Grants Policy, Office of Administration.
[FR Doc. 2016–21038 Filed 8–31–16; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–0001]
Advisory Committee; Cardiovascular
and Renal Drugs Advisory Committee,
Renewal
AGENCY:
Food and Drug Administration,
HHS.
[FR Doc. 2016–21047 Filed 8–31–16; 8:45 am]
BILLING CODE 4184–40–P
Notice; renewal of advisory
committee.
ACTION:
The Food and Drug
Administration (FDA) is announcing the
renewal of the Cardiovascular and Renal
Drugs Advisory Committee by the
Commissioner of Food and Drugs (the
Commissioner). The Commissioner has
determined that it is in the public
interest to renew the Cardiovascular and
Renal Drugs Advisory Committee for an
additional 2 years beyond the charter
expiration date. The new charter will be
in effect until August 27, 2018.
DATES: Authority for the Cardiovascular
and Renal Drugs Advisory Committee
will expire on August 27, 2016, unless
the Commissioner formally determines
that renewal is in the public interest.
FOR FURTHER INFORMATION CONTACT:
Jennifer Shepherd, Center for Drug
Evaluation and Research, Food and
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Announcement of the Award of SingleSource Grants Under the Wilson-Fish
Alternative Program (W–F); Correction;
CFDA Number: 93.583
Office of Refugee Resettlement,
ACF, HHS.
ACTION: Notice; correction.
AGENCY:
The Administration for
Children and Families (ACF), Office of
Refugee Resettlement (ORR), published
a document in the Federal Register of
August 22, 2016, concerning the
SUMMARY:
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
E:\FR\FM\01SEN1.SGM
01SEN1
Agencies
[Federal Register Volume 81, Number 170 (Thursday, September 1, 2016)]
[Notices]
[Pages 60355-60356]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-21039]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the Advisory
Committee to the Director, Centers for Disease Control and Prevention
(ACD, CDC)--Health Disparities Subcommittee (HDS)
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the ACD, CDC-HDS. This
subcommittee consists of up to 16 experts in fields related to health
policy, public health, global health, preparedness, preventive
medicine, the faith-based and community-based sector, and allied fields
who are selected by the CDC. The HDS provides interdisciplinary
perspectives and subject matter expertise to the goal of reducing
health disparities which may include research, program and policy
analyses, and other developmental activities for the ACD, CDC on CDC's
efforts to address health disparities which is integral to achieving
the agency's overarching health impact goals. Specifically, the HDS
will submit work products to the ACD, CDC for deliberation, discussion,
and decision.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishment of the
subcommittee's mission. Nominees will be selected by the Designated
Federal Officer of the ACD, CDC. Members may be invited to serve for
terms of up to three years.
The U.S. Department of Health and Human Services policy stipulates
that committee membership shall be balanced in terms of professional
training and background, points of view represented, and the
committee's function. Appointments shall be made without discrimination
on the basis of age, race, ethnicity, gender, sexual orientation,
gender identity, HIV status, disability, and cultural, religious, or
socioeconomic status. Nominees must be U.S. citizens, and cannot be
full-time employees of the U.S. Government. Current participation on
federal workgroups or prior experience serving on a federal advisory
committee does not disqualify a candidate; however, HHS policy is to
avoid excessive individual service on advisory committees and multiple
committee memberships. Subcommittee members are Special Government
Employees, requiring the filing of financial disclosure reports at the
beginning and annually during their terms.
Note that the need for different expertise varies from year to year
and a candidate who is not selected in one year may be reconsidered in
a subsequent year.
Nominees must be U.S. citizens, and cannot be full-time employees
of the U.S. Government. Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nomination materials must be date stamped by midnight on September
30, 2016 and sent to: ACDirector@cdc.gov or to Tracie Strength, Office
of the Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE., Mailstop D14, Atlanta, Georgia 30329. Please direct
questions to Tracie Strength at (404)498-6482.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and
[[Page 60356]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2016-21039 Filed 8-31-16; 8:45 am]
BILLING CODE 4163-18-P